Manuel Gurpegui (M Gurpegui)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Bipolar Disorder

Oxidative Stress

Top Venues

Journal of intellectual disability research : JIDR

Therapeutic drug monitoring

Bipolar disorders

This page only lists publications with an associated author ORCID identifier.

Publications

P J González-Domenech, Manuel Gurpegui, C M González-Domenech, S Gómez-González, A Rustarazo, V Ruiz-Nieto, M D Carretero, L Gutiérrez-Rojas
Prader-Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication. Journal of intellectual disability research : JIDR 68 (5) (2024)
P J González-Domenech, Manuel Gurpegui, C M González-Domenech, S Gómez-González, A Rustarazo, V Ruiz-Nieto, M D Carretero, L Gutiérrez-Rojas
Prader-Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication. Journal of intellectual disability research : JIDR (2024)
P J González-Domenech, Manuel Gurpegui, C M González-Domenech, S Gómez-González, A Rustarazo, V Ruiz-Nieto, M D Carretero, L Gutiérrez-Rojas
Prader-Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication. Journal of intellectual disability research : JIDR 68 (5) (2024)
Sara Jiménez-Fernández, Manuel Gurpegui, Christoph U Correll, Jose De Leon, Georgios Schoretsanitis
A Systematic Review of Clozapine Concentration-Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders. Therapeutic drug monitoring (2023)
Sara Jiménez-Fernández, Manuel Gurpegui, Daniel Garrote-Rojas, Luis Gutiérrez-Rojas, María D Carretero, Christoph U Correll
Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar disorders 23 (2) (2020)